FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/10/037589 [Registered on: 26/10/2021] Trial Registered Prospectively
Last Modified On: 19/01/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Use of two drug single or combination for prevention of nausea vomiting in caesarean 
Scientific Title of Study   Phenylepherine, ondensetron or a combination of both for prevention of intraoperative nausea and vomiting in patients undergoing lower segment caesarean section :a prospective ,double blind randomized control trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  PRATIBHA 
Designation  RESIDENT 
Affiliation  Rnt medical college 
Address  DEPARTMENT OF ANESTHESIA RNT MEDICAL COLLEGE MB HOSPITAL UDAIPUR RAJASTHAN

Udaipur
RAJASTHAN
313001
India 
Phone  8619094306  
Fax    
Email  PRAYADAV90@GMAIL.COM  
 
Details of Contact Person
Scientific Query
 
Name  DR VIKRAM BEDI 
Designation  SENIOR PROFESSOR 
Affiliation  Rnt medical college 
Address  DEPARTMENT OF ANESTHESIA RNT MEDICAL COLLEGE MB HOSPITAL UDAIPUR RAJASTHAN

Udaipur
RAJASTHAN
313001
India 
Phone  9829025373  
Fax    
Email  vbedimd@gmail.com  
 
Details of Contact Person
Public Query
 
Name  PRATIBHA 
Designation  RESIDENT 
Affiliation  Rnt medical college 
Address  DEPARTMENT OF ANESTHESIA RNT MEDICAL COLLEGE MB HOSPITAL UDAIPUR RAJASTHAN

Udaipur
RAJASTHAN
313001
India 
Phone  8619094306  
Fax    
Email  PRAYADAV90@GMAIL.COM  
 
Source of Monetary or Material Support  
No monetary /Material 
 
Primary Sponsor  
Name  DEPARTMENT OF ANESTHESIA 
Address  RNT MEDICAL COLLEGE MB HOSPITAL UDAIPUR RAJASTHAN 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
PRATIBHA  MAIN ZANANA OPERATION THEATER  SECOUND FLOOR MB HOSPITAL UDAIPUR RAJASTHAN
Udaipur
RAJASTHAN 
8619094306

PRAYADAV90@GMAIL.COM 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O80||Encounter for full-term uncomplicated delivery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  injection ondensetron   Patients will receive normal saline @15 ml/hr +injection ondensetron 4 mg (2ml) 
Comparator Agent  phenylepherine ,2 ml normal saline(placebo)  Patients will receive a prophylactic solution of 100microgm/ml of phenylepherine@15ml/hour (Dose 25microgm/min)+ 2 ml normal saline(placebo) 
Intervention  phenylepherine with bolus injection ondensetron  Patients will receive a prophylactic solution of 100microgm/ml of phenylepherine @15ml/hour (Dose 25microgm/min) with bolus injection ondensetron 4 mg(2 ml) 
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  This study will be carried out in term pregnant female patients with singleton pregnancy, taken up for elective Caesarean Section under spinal anaesthesia for various indications like previous Caesarean Section, breech presentation, cephalopelvic disproportion, pregnancy following infertility treatment, cord around neck, non progression of labour 
 
ExclusionCriteria 
Details  1.Patient refusal to participate in study
2.Emergency indication of Caesarean Section like antepartum haemorrhage, Placenta previa, abruptio placenta, fetal distress, obstructed labour, umbilical cord prolapse, preeclampsia, gestational diabetes, essential hypertension, more than two previous LSCS, history of PPH, multiple gestation.
3.Patients having contraindication for subarchnoid block.
4.Patient having associated systemic illness (hypo/hyperthyroidism, diabetic, neuromuscular disease ischemic/ valvular/ congenital heart disease, psychiatric, hematological disorder, SLE).
5.History of seizures, coma, neurological signs or symptoms (Eclampsia)
6.Any allergy to local anaesthetic or any drug.
H/o PONV 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Incidence of IONV  intraoperative 
 
Secondary Outcome  
Outcome  TimePoints 
Nausea score
Total consumption of phenylepherine in intraoperative period  
intraoperative 
 
Target Sample Size   Total Sample Size="195"
Sample Size from India="195" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="195" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/10/2021 
Date of Study Completion (India) 14/02/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details   research conducted as a dissertation 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Intraoperative nausea and vomiting (IONV) is one of the commonest and most distressing complications in patients undergoing Lower Segment Caesarean Section under subarchnoid block((SAB).This is thought to be multi factorial in causation.Contributing factors include intraoperative hypotension,vagal hyperactivity,opioids use,utero tonic drugs and visceral pain.

Therefore any intervention aimed at addressing one or more of these variable will be expected to decrease or abolish intraoperative nausea and vomiting.

Aims and objectives

To determine whether combination of phenylepherine infusion with bolus ondensetron is more effective in prevention of intraoperative nausea vomiting,when compare to bolus ondensetron or phenylepherine infusion alone in patients undergoing Lower Segment Caesarean Section under subarchnoid block

Primary outcome measured:  

1.Incidence of IONV (each episode = 1 incidence)

Secondary outcome

1. Nausea score

2. Total consumption of phenylepherine in intraoperative period 

As the study period starts all consecutive parturient females posted for Caesarean Section will be enrolled for the study if they fulfil the inclusion criteria till 195 patient (65 in each group) will be completed. 

 
Close